Operating Income - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Operating Income Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Operating Income
â‚Ş34.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Operating Income
$3.7B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
-1%
Redhill Biopharma Ltd
NASDAQ:RDHL
Operating Income
$4.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sol Gel Technologies Ltd
NASDAQ:SLGL
Operating Income
-$16.8m
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Operating Income
-$15.1m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Income
â‚Ş2.2m
CAGR 3-Years
-52%
CAGR 5-Years
-31%
CAGR 10-Years
-19%

See Also

What is InterCure Ltd's Operating Income?
Operating Income
34.3m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Operating Income amounts to 34.3m ILS.

What is InterCure Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
-46%

Over the last year, the Operating Income growth was -46%.

Back to Top